Flavivirus envelope protein fusion loop (FL)

The Flavivirus envelope (E) protein fusion loop (FL) is a highly conserved, hydrophobic peptide sequence located at the distal tip of domain II (EDII) of the viral envelope glycoprotein [4, 7]. It serves as the primary aromatic anchor that mediates the fusion of the viral envelope with the host cell's endosomal membrane during the entry process [17, 18]. Upon exposure to the acidic environment of the endosome, the E protein undergoes a dramatic conformational transition from a prefusion dimer to a postfusion trimer, projecting the fusion loop forward to insert into the target membrane [10, 17]. This mechanism is universal across the Flavivirus genus, including major pathogens such as Dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), and Yellow Fever virus (YFV) [1, 6]. From a therapeutic perspective, the fusion loop is a critical but challenging target. It is the site of action for numerous broadly cross-reactive monoclonal antibodies, such as 4G2 and E53, which aim to neutralize the virus by blocking membrane insertion [3, 14]. However, the fusion loop is also the principal driver of Antibody-Dependent Enhancement (ADE), a phenomenon where non-neutralizing or sub-neutralizing antibodies facilitate viral uptake into Fc-receptor-bearing cells, significantly increasing the risk of severe disease like Dengue Hemorrhagic Fever [2, 9]. Consequently, modern vaccine development often focuses on mutating or masking the fusion loop to redirect the immune response toward more potent, type-specific neutralizing epitopes while avoiding the risks associated with ADE [2, 6].

Other names

E-DII fusion loopHighly conserved fusion loopcd loopAromatic anchorFLEFusion loop epitope

Neutralization of viral entry by blocking membrane fusion and inhibiting the dimer-to-trimer conformational change; induction of antibody-dependent enhancement (ADE) at sub-neutralizing concentrations.